Advertisement
U.S. markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed Price. Currency in USD
162.12+0.74 (+0.46%)
At close: 04:00PM EST
162.10 -0.02 (-0.01%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Inside Bar (Bearish)

Inside Bar (Bearish)

Previous Close161.38
Open161.83
Bid161.81 x 800
Ask162.16 x 800
Day's Range161.09 - 162.57
52 Week Range144.95 - 175.97
Volume5,577,032
Avg. Volume7,211,061
Market Cap390.51B
Beta (5Y Monthly)0.54
PE Ratio (TTM)31.18
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield4.76 (2.95%)
Ex-Dividend DateFeb 16, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
13% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for JNJ

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Johnson & Johnson
    Analyst Report: Johnson & JohnsonJohnson & Johnson is a diversified healthcare company that develops, manufactures and markets products in two business segments: Innovative Medicine (formerly Pharmaceuticals) and MedTech.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more